Abstract:Background: Clinical trials are vital for developing new therapies but can also delay drug development. Efficient trial data management, optimized trial protocol, and accurate patient identification are critical for reducing trial timelines. Natural language processing (NLP) has the potential to achieve these objectives. Objective: This study aims to assess the feasibility of using data-driven approaches to optimize clinical trial protocol design and identify eligible patients. This involves creating a comprehensive eligibility criteria knowledge base integrated within electronic health records using deep learning-based NLP techniques. Methods: We obtained data of 3281 industry-sponsored phase 2 or 3 interventional clinical trials recruiting patients with non-small cell lung cancer, prostate cancer, breast cancer, multiple myeloma, ulcerative colitis, and Crohn disease from ClinicalTrials.gov, spanning the period between 2013 and 2020. A customized bidirectional long short-term memory- and conditional random field-based NLP pipeline was used to extract all eligibility criteria attributes and convert hypernym concepts into computable hyponyms along with their corresponding values. To illustrate the simulation of clinical trial design for optimization purposes, we selected a subset of patients with non-small cell lung cancer (n=2775), curated from the Mount Sinai Health System, as a pilot study. Results: We manually annotated the clinical trial eligibility corpus (485/3281, 14.78% trials) and constructed an eligibility criteria-specific ontology. Our customized NLP pipeline, developed based on the eligibility criteria-specific ontology that we created through manual annotation, achieved high precision (0.91, range 0.67-1.00) and recall (0.79, range 0.50-1) scores, as well as a high F1-score (0.83, range 0.67-1), enabling the efficient extraction of granular criteria entities and relevant attributes from 3281 clinical trials. A standardized eligibility criteria knowledge base, compatible with electronic health records, was developed by transforming hypernym concepts into machine-interpretable hyponyms along with their corresponding values. In addition, an interface prototype demonstrated the practicality of leveraging real-world data for optimizing clinical trial protocols and identifying eligible patients. Conclusions: Our customized NLP pipeline successfully generated a standardized eligibility criteria knowledge base by transforming hypernym criteria into machine-readable hyponyms along with their corresponding values. A prototype interface integrating real-world patient information allows us to assess the impact of each eligibility criterion on the number of patients eligible for the trial. Leveraging NLP and real-world data in a data-driven approach holds promise for streamlining the overall clinical trial process, optimizing processes, and improving efficiency in patient identification.

Automated classification of eligibility criteria in clinical trials to facilitate patient-trial matching for specific patient populations

Automatic trial eligibility surveillance based on unstructured clinical data

Establishing the Automatic Identification of Clinical Trial Cohorts from Electronic Health Records by Matching Normalized Eligibility Criteria and Patient Clinical Characteristics

Automated Matching of Patients to Clinical Trials: A Patient-Centric Natural Language Processing Approach for Pediatric Leukemia

ClinicalTrials.gov as a data source for semi-automated point-of-care trial eligibility screening

Automated clinical trial eligibility prescreening: increasing the efficiency of patient identification for clinical trials in the emergency department

Exploring the Generalization of Cancer Clinical Trial Eligibility Classifiers Across Diseases

An Ensemble Learning Strategy for Eligibility Criteria Text Classification for Clinical Trial Recruitment: Algorithm Development and Validation (Preprint)

An Ensemble Learning Strategy for Eligibility Criteria Text Classification for Clinical Trial Recruitment: Algorithm Development and Validation

Text Classification of Cancer Clinical Trial Eligibility Criteria

Phenotyping of clinical trial eligibility text from cancer studies into computable criteria in electronic health records.

A prospective study comparing AI-based clinical trial eligibility screening with traditional EMR-based screening.

CriteriaMapper: establishing the automatic identification of clinical trial cohorts from electronic health records by matching normalized eligibility criteria and patient clinical characteristics

Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation

Utilizing Large Language Models for Enhanced Clinical Trial Matching: A Study on Automation in Patient Screening

Automated classification of clinical trial eligibility criteria text based on ensemble learning and metric learning

Transformer-based Named Entity Recognition for Parsing Clinical Trial Eligibility Criteria

[Artificial intelligence based Chinese clinical trials eligibility criteria classification]

Clustering Clinical Trials with Similar Eligibility Criteria Features

Metastatic vs. Localized Disease As Inclusion Criteria That Can Be Automatically Extracted From Randomized Controlled Trials Using Natural Language Processing

Evaluating eligibility criteria of oncology trials using real-world data and AI